DTX2 and breast cancer: In the ion-binding category, the genes corresponded to genes encoding metal ion-binding proteins in 95% of cases: 28% encoding iron ion-binding and 23% with zinc ion-binding proteins (Figure 1B), pointing to a role of ion-binding proteins, and especially iron ion-binding proteins, in breast cancer with PIK3CA mutations.